Arteris, an IP supplier, recently developed its FlexGen IP for system-on-chip design. Design News caught up with Rick Bye, Arteris’s Director of Product Management and Marketing, to learn about the ...
News Medical on MSN
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results